Trials / Completed
CompletedNCT00840541
Phenotyping Diabetic Retinopathy
Observational Study of Type-2 Diabetic Subjects to Validate Diabetic Retinopathy Phenotypes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Association for Innovation and Biomedical Research on Light and Image · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to validate and characterize phenotypes of diabetic retinopathy (DR) progression based on available clinical data (demographic, systemic and ophthalmic data).
Detailed description
This study aims to validate and characterize phenotypes of diabetic retinopathy (DR) progression using ophthalmic and systemic data from type-2 diabetic subjects followed at the AIBILI Clinical Trial Center in the last 10 years. Macular Edema (ME) development during the study period, mainly Clinically Significant ME (CSME) needing treatment, will be the primary indicator for DR progression. CSME will be considered as the primary end-point and will be used to identify phenotypes (and risk markers) of DR progression.
Conditions
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2010-01-01
- Completion
- 2012-01-01
- First posted
- 2009-02-10
- Last updated
- 2014-04-07
Locations
1 site across 1 country: Portugal
Source: ClinicalTrials.gov record NCT00840541. Inclusion in this directory is not an endorsement.